EP 2705021 A2 20140312 - RASAGILINE AND ITS PHARMACEUTICALLY ACCEPTABLE SALTS
Title (en)
RASAGILINE AND ITS PHARMACEUTICALLY ACCEPTABLE SALTS
Title (de)
RASAGILIN UND PHARMAZEUTISCH ZULÄSSIGE SALZE DAVON
Title (fr)
RASAGILINE ET SES SELS PHARMACEUTIQUEMENT ACCEPTABLES
Publication
Application
Priority
- IN 1382MU2011 A 20110504
- IN 3169MU2011 A 20111109
- IN 2012000329 W 20120504
Abstract (en)
[origin: WO2012153349A2] The present invention relates to Rasagiline acid addition salts having a particle size D(90) greater than 250 microns and D(50) greater than 100 microns, with the proviso that acid addition salt is not mesylate. The invention also discloses a process for the preparation of such Rasagiline acid addition salts.
IPC 8 full level
C07C 211/42 (2006.01); C07C 309/29 (2006.01); C07C 309/35 (2006.01)
CPC (source: EP)
C07C 211/42 (2013.01); C07C 309/29 (2013.01); C07C 309/35 (2013.01); C07B 2200/13 (2013.01)
Citation (search report)
See references of WO 2012153349A2
Designated contracting state (EPC)
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated extension state (EPC)
BA ME
DOCDB simple family (publication)
WO 2012153349 A2 20121115; WO 2012153349 A3 20130321; WO 2012153349 A9 20140213; EP 2705021 A2 20140312
DOCDB simple family (application)
IN 2012000329 W 20120504; EP 12766333 A 20120504